Log In
Print this Print this

Vancocin, vancomycin

Also known as: Vancocin Pulvules

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionTricyclic glycopeptide antibiotic
Molecular Target D-alanyl-D-alanine
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationDiarrhea (infectious)
Indication DetailsTreat staphylococcal enterocolitis, Clostridium difficile-associated colitis and Clostridium difficile-associated diarrhea (CDAD) infections
Regulatory Designation
PartnerANI Pharmaceuticals Inc.;
ANI Pharmaceuticals Inc.;
Eddingpharm Inc.;
Merus Labs International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today